DEA targets digital health firm Truepill for stimulant dispensing

The Drug Enforcement Administration has alleged that telehealth and digital pharmacy company Truepill unlawfully dispensed thousands of prescriptions for stimulant medications such as Adderall used in the treatment of attention-deficit/hyperactivity disorder, Fierce Healthcare reports. The DEA asserted that between September 2020 and September 2022, Truepill filled more than 72,000 controlled substance prescriptions, 60% of which were for stimulants.